Published in Schizophr Res on May 23, 2009
Psychiatrists' perceptions of the clinical importance, assessment and management of patient functioning in schizophrenia in Europe, the Middle East and Africa. Ann Gen Psychiatry (2013) 0.80
Construct Validity of the Chinese Version of the Activities of Daily Living Rating Scale III in Patients with Schizophrenia. PLoS One (2015) 0.75
The Youth Mental Health Risk and Resilience Study (YouR-Study). BMC Psychiatry (2017) 0.75
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov (2012) 2.44
Ketamine administration in depressive disorders: a systematic review and meta-analysis. Psychopharmacology (Berl) (2014) 2.37
Evaluating the impact of a quality of life assessment with feedback to clinicians in patients with schizophrenia: randomised controlled trial. Br J Psychiatry (2013) 2.12
Genetics of dopamine receptors and drug addiction: a comprehensive review. Behav Pharmacol (2009) 1.72
A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med (2012) 1.67
Is DSM-IV bereavement exclusion for major depression relevant to treatment response? A case-control, prospective study. J Clin Psychiatry (2010) 1.45
Mortality in schizophrenia. Pharmacoepidemiol Drug Saf (2006) 1.41
Diogenes syndrome in a pair of siblings. Can J Psychiatry (2003) 1.40
[Depression in general practitioner]. Presse Med (2012) 1.38
The Modified Reasons for Smoking Scale: factorial structure, gender effects and relationship with nicotine dependence and smoking cessation in French smokers. Addiction (2003) 1.37
Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable vs quetiapine: results of a long-term, open-label, randomized clinical trial. Neuropsychopharmacology (2010) 1.31
Executive dysfunctions as potential markers of familial vulnerability to bipolar disorder and schizophrenia. Psychiatry Res (2004) 1.27
Prevalence of mental disorders in French prisons for men. BMC Psychiatry (2006) 1.25
Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations. Hum Mol Genet (2004) 1.20
The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in France. Curr Med Res Opin (2003) 1.20
DYRK1A interacts with the REST/NRSF-SWI/SNF chromatin remodelling complex to deregulate gene clusters involved in the neuronal phenotypic traits of Down syndrome. Hum Mol Genet (2009) 1.19
Assessing and interpreting personality change and continuity in patients treated for major depression. Psychol Assess (2006) 1.18
Association of BDNF with restricting anorexia nervosa and minimum body mass index: a family-based association study of eight European populations. Eur J Hum Genet (2005) 1.13
Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial. J Clin Psychiatry (2009) 1.12
Cancer mortality in patients with schizophrenia: an 11-year prospective cohort study. Cancer (2009) 1.12
Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer. J Clin Psychiatry (2003) 1.11
GOSPEL: prospective survey of gout in France. Part I: design and patient characteristics (n = 1003). Joint Bone Spine (2012) 1.11
Efficacy of light therapy in nonseasonal depression: a systematic review. J Affect Disord (2007) 1.10
SMARCA2 and other genome-wide supported schizophrenia-associated genes: regulation by REST/NRSF, network organization and primate-specific evolution. Hum Mol Genet (2010) 1.07
Is hormonal therapy associated with better quality of life in transsexuals? A cross-sectional study. J Sex Med (2011) 1.06
The etiology of behavioral problems and competencies in very young twins. J Abnorm Psychol (2008) 1.06
Psychopathology and comorbidity of psychiatric disorders in patients with kleptomania. Am J Psychiatry (2003) 1.06
Massively multiplayer online role-playing games: comparing characteristics of addict vs non-addict online recruited gamers in a French adult population. BMC Psychiatry (2011) 1.05
[Epidemiology of schizophrenic disorders]. Presse Med (2006) 1.05
Quality of life among caregivers of individuals with affective disorders. J Affect Disord (2011) 1.05
DSM bereavement exclusion for major depression and objective cognitive impairment. J Affect Disord (2010) 1.05
Convergent evidence identifying MAP/microtubule affinity-regulating kinase 1 (MARK1) as a susceptibility gene for autism. Hum Mol Genet (2008) 1.03
A first national survey of knowledge, attitudes and behaviours towards schizophrenia, bipolar disorders and autism in France. BMC Psychiatry (2012) 1.02
Negative affectivity, self-referential processing and the cortical midline structures. Soc Cogn Affect Neurosci (2010) 1.01
Improving treatment adherence in your patients with schizophrenia: the STAY initiative. Clin Drug Investig (2013) 0.99
Psychological distress in first year university students: socioeconomic and academic stressors, mastery and social support in young men and women. Soc Psychiatry Psychiatr Epidemiol (2008) 0.99
The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia. Eur Neuropsychopharmacol (2007) 0.98
The 3' region of the DRD2 gene is involved in genetic susceptibility to schizophrenia. Schizophr Res (2004) 0.98
Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness. BMC Psychiatry (2013) 0.97
Nrxn3 upregulation in the globus pallidus of mice developing cocaine addiction. Neuroreport (2008) 0.97
Factors associated with rapid cycling in bipolar I manic patients: findings from a French national study. CNS Spectr (2008) 0.97
Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction. Schizophr Res (2006) 0.96
Measuring quality of life in patients with schizophrenia:an overview. Expert Rev Pharmacoecon Outcomes Res (2013) 0.96
[Clinical features and psychopathology of factitious disorders]. Ann Med Interne (Paris) (2002) 0.96
The psychological impact of terrorism: an epidemiologic study of posttraumatic stress disorder and associated factors in victims of the 1995-1996 bombings in France. Am J Psychiatry (2004) 0.95
Striatal dopamine transporter levels correlate with apathy in neurodegenerative diseases A SPECT study with partial volume effect correction. Clin Neurol Neurosurg (2007) 0.95
Validating antidepressant-associated hypomania (bipolar III): a systematic comparison with spontaneous hypomania (bipolar II). J Affect Disord (2003) 0.94
Bipolar patients with suicidal behavior: toward the identification of a clinical subgroup. J Clin Psychiatry (2004) 0.94
Clozapine treatment of a borderline personality disorder with severe self-mutilating behaviours. Eur Psychiatry (2004) 0.94
Psychiatric disorders in students in six French universities: 12-month prevalence, comorbidity, impairment and help-seeking. Soc Psychiatry Psychiatr Epidemiol (2009) 0.94
Ten-year prospective follow-up study of the mortality by suicide in schizophrenic patients. Schizophr Res (2007) 0.93
Gene-environment interactions in addictive disorders: epidemiological and methodological aspects. C R Biol (2007) 0.92
Familial aggregation of delusional proneness in schizophrenia and bipolar pedigrees. Am J Psychiatry (2003) 0.92
Severe anorexia nervosa in men: comparison with severe AN in women and analysis of mortality. Int J Eat Disord (2012) 0.92
The role of brief motivational intervention on self-efficacy and abstinence in a cohort of patients with alcohol dependence. Int J Psychiatry Med (2009) 0.91
The 3' part of the dopamine transporter gene DAT1/SLC6A3 is associated with withdrawal seizures in patients with alcohol dependence. Alcohol Clin Exp Res (2007) 0.91
Molecular genetics of alcohol dependence and related endophenotypes. Curr Genomics (2008) 0.90
Family trios analysis of common polymorphisms in the obestatin/ghrelin, BDNF and AGRP genes in patients with Anorexia nervosa: association with subtype, body-mass index, severity and age of onset. Psychoneuroendocrinology (2007) 0.90
Mortality in schizophrenia. Pharmacoepidemiol Drug Saf (2007) 0.90
Anhedonia in schizophrenia: a distinct familial subtype? Schizophr Res (2003) 0.90
First positive reactions to cannabis constitute a priority risk factor for cannabis dependence. Addiction (2009) 0.90
A new definition of early age at onset in alcohol dependence. Drug Alcohol Depend (2009) 0.89
The short allele of the serotonin transporter promoter polymorphism influences relapse in alcohol dependence. Alcohol Alcohol (2008) 0.89
Self-reported quality of life measure is reliable and valid in adult patients suffering from schizophrenia with executive impairment. Schizophr Res (2013) 0.89
The role of genes involved in neuroplasticity and neurogenesis in the observation of a gene-environment interaction (GxE) in schizophrenia. Curr Mol Med (2009) 0.89
The executive control of attention differentiates patients with schizophrenia, their first-degree relatives and healthy controls. Neuropsychologia (2010) 0.89
Association between dopamine receptor D1 gene DdeI polymorphism and sensation seeking in alcohol-dependent men. Alcohol Clin Exp Res (2003) 0.88
Validating the bipolar spectrum in the French National EPIDEP Study: overview of the phenomenology and relative prevalence of its clinical prototypes. J Affect Disord (2006) 0.88
Self-intoxication with baclofen in alcohol-dependent patients with co-existing psychiatric illness: an emergency department case series. Alcohol Alcohol (2013) 0.87
Determinants of early identification of suicidal ideation in patients treated with antidepressants or anxiolytics in general practice: a multilevel analysis. J Affect Disord (2006) 0.87
A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD). Neuropsychopharmacology (2009) 0.87
Investigation of impulsivity in a sample of treatment-seeking pathological gamblers: a multidimensional perspective. Psychiatry Res (2012) 0.87
Relationship between circadian typology and functional and dysfunctional impulsivity. Chronobiol Int (2010) 0.87
Psychiatrists' awareness of adherence to antipsychotic medication in patients with schizophrenia: results from a survey conducted across Europe, the Middle East, and Africa. Patient Prefer Adherence (2013) 0.87
Maintenance transcranial magnetic stimulation reduces depression relapse: a propensity-adjusted analysis. J Affect Disord (2013) 0.87
Ageing and trajectories of depressive symptoms in community-dwelling men and women. Int J Geriatr Psychiatry (2013) 0.87
Circadian typology and temperament and character personality dimensions. Chronobiol Int (2010) 0.86
A genetic schizophrenia-susceptibility region located between the ANKK1 and DRD2 genes. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.86
Genetics and personality affect visual perspective in autobiographical memory. Conscious Cogn (2009) 0.86
Predictors of dropout from inpatient treatment for anorexia nervosa: data from a large French sample. Psychiatry Res (2010) 0.86
Schizophrenia with preserved insight is associated with increased perfusion of the precuneus. J Psychiatry Neurosci (2012) 0.86
Neurobiology of attention deficit/hyperactivity disorder. Pediatr Res (2011) 0.85
Low socioeconomic position and depression persistence: longitudinal results from the GAZEL cohort study. Psychiatry Res (2010) 0.85
Temperament in schizophrenia: a study of the tridimensional personality questionnaire (TPQ). Eur Psychiatry (2002) 0.85
Association of NTRK3 and its interaction with NGF suggest an altered cross-regulation of the neurotrophin signaling pathway in eating disorders. Hum Mol Genet (2008) 0.85
Admixture analysis of age at onset in schizophrenia. Schizophr Res (2004) 0.85
Temperament and character dimensions associated with clinical characteristics and treatment outcome in attention-deficit/hyperactivity disorder boys. Compr Psychiatry (2010) 0.85
Cognitive appraisal and life stress moderate the effects of the 5-HTTLPR polymorphism on amygdala reactivity. Hum Brain Mapp (2011) 0.85
Risk factors associated with lifetime suicide attempts in bipolar I patients: findings from a French National Cohort. Compr Psychiatry (2008) 0.84
Psychopathological correlates of lifetime anxiety comorbidity in bipolar I patients: findings from a French national cohort. Psychopathology (2009) 0.84
Determinants of coprescription of anxiolytics with antidepressants in general practice. Can J Psychiatry (2008) 0.84
Factors associated with suicidal behaviors in a large French sample of inpatients with eating disorders. Int J Eat Disord (2007) 0.84
Equivalent brain SPECT perfusion changes underlying therapeutic efficiency in pharmacoresistant depression using either high-frequency left or low-frequency right prefrontal rTMS. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.83
[Virtual reality in the treatment of mental disorders]. Presse Med (2013) 0.83
Lazabemide, a selective, reversible monoamine oxidase B inhibitor, as an aid to smoking cessation. Addiction (2002) 0.83
Serotonin transporter gene polymorphism influences age at onset in patients with bipolar affective disorder. Neurosci Lett (2002) 0.83